The city of Knoxville, Tennessee, currently has 1 active clinical trials seeking participants for Osteoarthritis research studies.
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
Recruiting
This study is a prospective, multicenter (up to 4 sites), randomized, double-blind, two-arm study. Forty-five (45) patients will be randomized to receive a single 4-6 ml intra-articular (IA) injection of either the output of ACP Max™ (n=30) or 6 ml of Depo-Medrol® (methylprednisolone acetate) (n=15).
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/23/2024
Locations: AMR Knoxville, Knoxville, Tennessee
Conditions: Knee Osteoarthritis